Family Medicine · Indio, CA
NPI
1013002435
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
81719 Dr Carreon Blvd Ste F
Indio, CA, 92201
Phone (760) 462-6880
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
205 services
Medicare patients, 2024
53
Average age 68
Drug cost, 2024
$2.2M
19,357 prescriptions
Company payments, 2025
$798
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Albert R Anderson III was code 99214 (office e&m - established), 96 times for 47 patients. In total Albert R Anderson III billed 205 services in 14 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 96 | 47 | $94.96 | $9,116 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 54 | 33 | $12.46 | $673 |
| 99204 Office E&M - New | Office | 11 | 11 | $123.95 | $1,363 |
By year: 2022 $2,702 for 79 services; 2023 $3,469 for 53 services; 2024 $14K for 205 services.
Medicare prescription drug claims, 2024
In 2024, the drug Albert R Anderson III prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,745 prescriptions and refills. In total Albert R Anderson III wrote 19,357 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,745 | 4,925 | 593 | $21K |
| Metformin Hcl Generic | 905 | 2,549 | 314 | $8,186 |
| Lisinopril Generic | 893 | 2,608 | 305 | $7,904 |
| Amlodipine Besylate Generic | 881 | 2,403 | 288 | $5,250 |
| Losartan Potassium Generic | 623 | 1,714 | 208 | $6,942 |
| Levothyroxine Sodium Generic | 606 | 1,647 | 188 | $9,302 |
| Tamsulosin Hcl Generic | 415 | 1,175 | 150 | $6,303 |
| Omeprazole Generic | 376 | 993 | 122 | $5,035 |
| Gabapentin Generic | 356 | 748 | 109 | $6,424 |
| Pantoprazole Sodium Generic | 349 | 813 | 112 | $3,268 |
| Olmesartan Medoxomil Generic | 346 | 927 | 110 | $5,989 |
| Metoprolol Succinate Generic | 313 | 839 | 100 | $4,146 |
| Hydrochlorothiazide Generic | 313 | 882 | 109 | $1,299 |
| Carvedilol Generic | 268 | 702 | 89 | $2,863 |
| Ibuprofen Generic | 252 | 295 | 83 | $2,778 |
Brand drugs: 2,579 claims; generic drugs: 16,565 claims; opioid claims: 538.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Albert R Anderson III $798 ($798 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $398.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $398 |
| GlaxoSmithKline, LLC. GSK | 11 | $157 |
| Boston Scientific Corporation BSX | 1 | $133 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $23.36 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $22.75 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $18.78 |
| Pfizer Inc. PFE | 1 | $15.95 |
| Amgen Inc. AMGN | 1 | $14.14 |
| CeQur Corporation | 1 | $13.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.